Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
45.25
+0.22 (+0.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crispr Therapeutics Ag
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
The Ultimate Growth Stock to Buy With $1,000 Right Now
January 08, 2024
The stock, trading for about $60, has plenty of room to run.
Via
The Motley Fool
5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024
January 06, 2024
You'll find exciting innovators across industries.
Via
The Motley Fool
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
2 Biotech Stocks With Huge Catalysts in 2024
January 05, 2024
Important clinical-trial readouts on the way could send these stocks soaring in early 2024.
Via
The Motley Fool
Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
January 01, 2024
Via
Benzinga
Could CRISPR Therapeutics Stock Help You Become a Millionaire?
December 22, 2023
There are plenty of reasons to be optimistic about CRISPR's future.
Via
The Motley Fool
Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors
January 04, 2024
Gen Z stocks include companies the generation prefers to invest in while capturing the emerging economic force they represent.
Via
InvestorPlace
Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics
January 04, 2024
CRISPR Therapeutics' shares climbed considerably last year -- but more gains could be just ahead.
Via
The Motley Fool
3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition
January 03, 2024
Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.
Via
InvestorPlace
Better Risky Investment: Bluebird Bio vs. Shiba Inu
January 03, 2024
Few investors dare to tread where the ice is known to be very thin.
Via
The Motley Fool
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.
Via
InvestorPlace
3 No-Brainer Growth Stocks to Buy for Less Than $100
January 01, 2024
These businesses have promising futures and make for great investment options today.
Via
The Motley Fool
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
December 31, 2023
Ark Invest holds a hefty position in this gene-editing stock. Risk-tolerant investors may want to take a page from the fund's playbook on this name.
Via
The Motley Fool
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
Curing rare inherited illnesses could be a lucrative business model.
Via
The Motley Fool
2023 in Review: Nvidia, Interest Rates, Taylor Swift
December 30, 2023
And a little bit of real estate insight.
Via
The Motley Fool
3 Stocks That Could Be Monster Winners in 2024
December 30, 2023
Don't be surprised if these three stocks take off in the new year.
Via
The Motley Fool
AI and Automation Leaders for 2024: 7 Stocks to Stay Ahead of the Robot Uprising
December 30, 2023
With the robotics revolution taking over multiple industries, investors have options.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Top Stocks to Buy Hand Over Fist Before the End of 2023
December 25, 2023
These are ideal stocks to buy sooner rather than later.
Via
The Motley Fool
3 Healthcare Technology Stocks to Improve Lives in 2024
December 25, 2023
Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.
Via
InvestorPlace
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
December 23, 2023
The stock has been in the news lately.
Via
The Motley Fool
Cathie Wood Predicts Deflation In 2024, More AI And Tech Optimism — And Rate Cuts
December 22, 2023
Cathie Wood believes deflation in 2024, aggressive rate cuts and technological progress will drive expansion.
Via
Benzinga
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024
December 22, 2023
Doing a little math and doing a little extra research can make a big difference.
Via
The Motley Fool
I'm Begging You to Buy Stocks Before January -- Here's Why
December 22, 2023
Some studies have shown a pattern of market gains in the month of January.
Via
The Motley Fool
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?
December 22, 2023
The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.
Via
The Motley Fool
Exposures
Product Safety
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy
December 21, 2023
Should you buy CRISPR's stock on the dip?
Via
The Motley Fool
Exposures
Product Safety
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock
December 21, 2023
These stocks are currently going in different directions, but both could go up in a new bull market.
Via
The Motley Fool
Is Vertex Pharmaceuticals Sitting on a Gold Mine?
December 21, 2023
Vertex shares have climbed about 40% this year.
Via
The Motley Fool
CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief
December 20, 2023
The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.
Via
InvestorPlace
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
December 20, 2023
CRISPR Therapeutics stock has increased in the double digits this year.
Via
The Motley Fool
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Via
InvestorPlace
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.